|
|
|
|
|
|
|
||
© The Rockefeller University Press,
0021-9525/1999//59 $5.00
The Journal of Cell Biology, Volume 144, Number 1,
, 1999 59-69
Article |
Vinexin: A Novel Vinculin-binding Protein with Multiple SH3 Domains Enhances Actin Cytoskeletal Organization
Laboratory of Biochemistry, Division of Applied Life Science, Kyoto University, Kyoto 606-01, Japan; Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Science, Research Triangle Park, North Carolina 27709; and || Biomolecular Engineering Research Institute, Osaka 565-0874, Japan
Using the yeast two-hybrid system and an in vitro binding assay, we have identified a novel protein termed vinexin as a vinculin-binding protein. By Northern blotting, we identified two types of vinexin mRNA that were 3 and 2 kb in length. Screening for full-length cDNA clones and sequencing indicated that the two mRNA encode 82- and 37-kD polypeptides termed vinexin
and β, respectively. Both forms of vinexin share a common carboxyl-terminal sequence containing three SH3 domains. The larger vinexin contains an additional amino-terminal sequence. The interaction between vinexin and vinculin was mediated by two SH3 domains of vinexin and the proline-rich region of vinculin. When expressed, vinexin and β localized to focal adhesions in NIH 3T3 fibroblasts, and to cell–cell junctions in epithelial LLC-PK1 cells. Furthermore, expression of vinexin increased focal adhesion size. Vinexin also promoted upregulation of actin stress fiber formation. In addition, cell lines stably expressing vinexin β showed enhanced cell spreading on fibronectin. These data identify vinexin as a novel focal adhesion and cell– cell adhesion protein that binds via SH3 domains to the hinge region of vinculin, which can enhance actin cytoskeletal organization and cell spreading.
Key Words: actin cytoskeleton • cell adhesion • focal adhesion • SH3 domain • vinculin
Abbreviations used in this paper: GFP, green fluorescent protein; GST, glutathione S-transferase; VASP, vasodilator-stimulated phosphoprotein.
VINCULIN is an abundant cytoskeletal protein found in integrin-mediated cell-substrate adhesion sites (focal adhesions) and also in cadherin-mediated cell–cell adhesions (adherens junctions). Vinculin binds in vitro to cytoskeletal proteins such as talin, paxillin, -actinin, and F-actin. By complex formation with these cytoskeletal proteins, vinculin is thought to contribute to organization of the actin cytoskeleton induced by integrin-meditated cell adhesion (Jockusch et al., 1995; Yamada and Geiger, 1997). Indeed, elevation or knock out of vinculin expression results in substantial alteration of cell adhesivity and motility (Rodríguez Fernández et al., 1993; Varnum-Finney and Reichardt, 1994; Coll et al., 1995; Goldmann et al., 1995; Volberg et al., 1995).
From studies with proteolytic fragments of vinculin and electron microscopy, vinculin appears to be composed of a large globular "head" domain and a rod-like "tail" domain (Milam, 1985; Molony and Burridge, 1985). The head domain binds to -actinin and to talin, whereas the tail domain binds to F-actin and to the vinculin tail domain itself in an intermolecular interaction (for a review, see Jockusch et al., 1995). In the hinge region between the head and tail domains, vinculin has a short proline-rich sequence.
To date, many cytoskeletal proteins have been identified in focal adhesion and adherens junctions. Although numerous studies have elucidated the functions of these proteins and their interactions, little is known about the regulation of the topology of these interactions. Interestingly, the intramolecular interaction between the head and tail domain of vinculin has been suggested to modulate its interaction with the other cytoskeletal proteins, talin (Johnson and Craig, 1994), -actinin (Kroemker et al., 1994), and F-actin (Johnson and Craig, 1995), as well as serine/threonine phosphorylation (Schwienbacher et al., 1996). Furthermore, phosphatidylinositol-4,5-bisphosphate (PIP2) has been found to dissociate vinculin's head– tail interaction, unmasking its talin- and actin-binding sites (Gilmore and Burridge, 1996; Weekes et al., 1996). Therefore, alteration of the conformation of vinculin is a potential regulatory mechanism for actin cytoskeletal changes. Because of the potentially important location of the proline-rich region of vinculin and a high degree of sequence conservation of this region from Caenorhabditis elegans to human, we screened for binding proteins to this region using the yeast two-hybrid system. Here we report the identification and characterization of a novel vinculin-binding protein designated as vinexin.
 |
Materials and Methods |
|---|
 TopAbstract Materials and Methods ResultsDiscussionReferences |
|---|
|
To isolate full-length vinexin cDNA, a human HeLa 5'-stretch plus cDNA library (Clontech) and a mouse 13.5-d embryo cDNA library (kindly provided by Dr. Yoshihiko Yamada, National Institutes of Health [NIH], Bethesda, MD) were screened by plaque hybridization using the insert of the positive clone as a probe. The probe was labeled with 32P using a randomly primed DNA labeling kit (Boehringer Mannheim).
Mapping of the Vinculin Binding Site
To map the vinculin binding site in the vinexin sequence, the yeast two-hybrid system was used to detect interactions between deletion mutants of vinexin and vinculin proline-rich regions. Primer pairs N1 (5'AATGAATTCGCCGCCAGGCTCAAGTTT3') and C1 (5'AATGTCGACGGGCAGCACCTCCACATA3'), N2 (5'GAAGAATTCGAGGTTGTGGCCCAGT3'), and C2 (5'TATGTCGACTTCACGAGACACCTGC3'), and N1 and C2 were used for PCR to construct the plasmids pGAD1stSH3, pGAD2ndSH3, and pGAD1st2ndSH3, respectively. The resulting PCR products were digested with EcoRI and SalI and ligated into pGAD424 and sequenced. PCR was also used to amplify the deleted vinculin proline-rich region, pGB410d1 and pGB410d2, with primer pairs 729A (5'GCCGAATTCCATCTCCATCTGACTGATG3') and 410, and 729B (5'AGAGAATTCCCAGAAGGTGAGGTTCCC3') and 410, respectively. The PCR products were digested with EcoRI and SalI and subcloned into pGBT9.
After cotransformation of HF7c with the vinculin proline-rich region in pGBT9 and the vinexin deletion mutants in pGAD424, transformants were assayed for β galactosidase activity on filters or in solution.
In Vitro Binding Assay Using Affinity Precipitation
For an in vitro binding assay, various glutathione S-transferase (GST)1 fusion proteins were expressed in Escherichia coli using the inserts of pGAD424 plasmids described above and GST expression plasmid pGEX-4T-1 (Pharmacia Fine Chemicals). To construct a GST fusion protein containing the first SH3 domain and a linker region between the two SH3 domains (clone pGAD1stSH3L), primer pairs N1 and CL (5'AATGTCGACTCCATACTCCAGCACCTG3') were used for PCR, and the product was subcloned into pGEX-4T-1. GST fusion proteins were expressed in E. coli and purified with glutathione Sepharose 4B (Pharmacia Fine Chemicals) according to the supplier's instructions. Cultured human foreskin fibroblasts (kindly provided by Susan Yamada, NIH) were washed twice with PBS and lysed in NP-40 lysis buffer (0.5% NP-40, 100 µg/ml PMSF, 10 µg/ml aprotinin, 0.1 mM sodium orthovanadate). The lysate containing 400 µg total protein as estimated by microBCA assay (Pierce Chemical Co.) was incubated with 5 µg each of GST fusion protein and glutathione-Sepharose 4B at 4°C for 16 h. After four washes with lysis buffer, proteins were extracted from the Sepharose beads by boiling in loading buffer, resolved by 8% SDS-PAGE, and transferred to an Immobilon-P membrane (Millipore Corp.). Coprecipitated vinculin was detected by Western blotting using anti–human vinculin monoclonal antibody VII-F9 (a kind gift of Dr. Victor Koteliansky, Biogen, Inc., Cambridge, MA).
Northern Blotting
The cDNA of vinexin was labeled as described above and used to probe the human multiple tissue Northern blot (Clontech) containing 2 µg of polyA+ RNA.
Production of Polyclonal Antibody
Rabbit antiserum was raised against a recombinant vinexin fragment expressed by histidine-tagged bacterial expression vector pET22a (Novagen, Madison, WI) containing the vinexin cDNA insert of the clone (pVBP) isolated by the yeast two-hybrid screening. Polyclonal antibodies were affinity-purified using the recombinant protein covalently conjugated to Affigel 10 (Bio-Rad Laboratories). The bound antibodies were subsequently passed through an Affigel 10 column conjugated with E. coli whole protein extract to remove nonspecific antibodies.
Cell Lines
NIH 3T3, HeLa, C2C12, and LLC-PK1 cells were originally obtained from American Type Culture Collection and maintained in our laboratory. Mouse myoblastic C2C12 cells (Yaffe and Saxel, 1977) were induced to differentiate to myotubes by culturing with 10% horse serum for 6 d. Porcine kidney epithelial LLC-PK1 cells (Tanigawara et al., 1992) form a highly polarized monolayer, and were used to test vinexin localization in an epithelial cell.
Western Blotting
Cells were extracted with lysis buffer (1.0% Triton X-100, 1.0% sodium deoxycholate, 0.1% SDS) containing 100 µg/ml PMSF, 10 µg/ml aprotinin, 10 µg/ml leupeptin, and 2.5 mM EGTA. Extracted proteins (80 µg) were boiled in loading buffer for 3 min, resolved by 8% SDS-PAGE, and transferred to an Immobilon-P membrane. The filter was blocked with Block Ace (Dainippon Pharmaceutical), incubated with 0.66 µg/ml affinity-purified anti–vinexin antibody for 1 h, rinsed in TBS (100 mM Tris, pH 7.5, 150 mM NaCl) containing 0.1% Tween 20. Immune complexes were visualized with goat anti–rabbit IgG horseradish peroxidase–conjugated secondary antibody (Bio-Rad Laboratories) and developed using the ECL kit (Amersham International).
Subcellular Localization of Vinexin
Mouse vinexin and β were tagged with Green Fluorescent Protein (GFP) or FLAG epitope (Eastman Kodak Co.) at the amino termini using the expression plasmids pGZ21 or p401F, respectively. pGZ21 contains a cytomegalovirus promoter and a GFP coding sequence with three amino acid residue substitutions (S65A, V68L, and S72A) to increase its fluorescence in mammalian cells (Cormack et al., 1996). Plasmid p401F is similar to pGZ21, but contains the FLAG epitope instead of GFP, and a neomycin-resistance gene for G418 selection. To construct the expression plasmid for the GFP-tagged amino-terminal half of vinexin (pGFPVxH), an internal AccI restriction site was used to delete the carboxy-terminal half of vinexin . PCR was used to amplify the DNA fragment for the third SH3 domain to construct pGFP3rdSH3.
NIH 3T3 cells were plated on coverslips 24 h after transfection of the expression plasmids using LipofectAMINE (Life Technologies, Inc.). We routinely observed that 
10–40% of the treated cells expressed vinexin or its fragments directed by each respective expression plasmid. After 24 h further incubation, the cells were fixed in 4% paraformaldehyde and 5% sucrose in PBS+ (PBS with 0.87 mM CaCl2, 0.49 mM MgCl2) for 30 min, and permeabilized for 5 min in 0.4% Triton X-100 in PBS+. The cells were blocked with 10% goat serum in PBS+ for 1 h, followed by incubation with antivinculin antibody. The cells were then stained with Texas Red–labeled sheep anti–mouse IgG anti-body (Amersham International) for 1 h. For F-actin staining, rhodamine-phalloidin (Molecular Probes, Inc.) was used. The fluorescence images were photographed by an Axiovert fluorescent microscope equipped with epifluorescence (Carl Zeiss Jena). For observing GFP fluorescence, a filter set for FITC supplied by Carl Zeiss Jena was used. The confocal microscope images were obtained using a Fluoview Confocal Laser Scanning microscope (Olympus Corp.).
Cell-spreading Assay
FLAG-tagged vinexin expression plasmids were constructed using the vector p401F described above. Geneticin at 800 µg/ml (Life Technologies, Inc.) was added to C2C12 cells 48 h after transfection with expression plasmids for FLAG-tagged vinexin , vinexin β, or p401F alone. Geneticin-resistant clones expressing vinexin were selected and assayed by Western blotting. In a cell-spreading assay (Aota et al., 1994), cells were allowed to adhere and spread for 1 h on human plasma fibronectin coated at 1 µg/ml.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
As shown in Fig. 2, we detected two types of mRNA molecules by Northern blotting that were 3 and 2 kb in length. The two mRNA species showed varying levels of expression in different human tissues. The 2-kb mRNA molecule was generally expressed at higher levels than the 3-kb molecule, and an especially high expression level was detected in heart for the 2-kb molecule. In contrast, a high expression level of the 3-kb molecule was observed in skeletal muscle. Interestingly, vinculin expression levels roughly correlated with the combined expression levels of the two types of vinexin mRNA molecule (Fig. 2).
|
and β, respectively. Vinexin β corresponds to the carboxyl-terminal half of vinexin (Fig. 3 B). Since the 5' end of the untranslated region of the cDNA clones from HeLa cells has a unique sequence not found so far in vinexin cDNA clones, it is likely that two distinct alternative promoters give rise to the two different mRNA molecules.
|
and β were detected. Interestingly, downregulation of vinexin β was detected after induction of C2C12 differentiation. In HeLa and differentiated C2C12 cells, additional bands of 30 and 75 kD were detected, indicating that there may be additional subtypes of vinexin, or, less likely, protein degradation.
|
and β share a common carboxyl-terminal sequence that contains the three SH3 domains. Clone pVBP isolated by the yeast two-hybrid screening contains the first and second SH3 domains (Fig. 3). To map the region for vinculin binding, various segments of vinexin were fused with the GAL4 activation domain in the plasmid pGAD424 (Fig. 5 A). They were introduced into the yeast strain HF7c with plasmid pGB410, which contains the proline-rich region of vinculin fused with the GAL4 DNA-binding domain. The results of β galactosidase activity assays for each clone are shown in Fig. 5 B. Vinculin binding was not detected with either the first or second SH3 domain alone, whereas the clone with the first two SH3 domains showed vinculin binding.
|
|
|
and β (Fig. 8) were transfected into NIH 3T3 cells. The subcellular localization of vinexin was observed by GFP fluorescence, and the same cells were also stained with antivinculin monoclonal antibody VII-F9 and a Texas Red–labeled second antibody (Fig. 9). Both GFP-fused vinexin isoforms were predominantly localized at focal adhesions, and both colocalized with endogenous vinculin, although vinexin β was also found in the cytoplasm and sometimes in the nucleus. In NIH 3T3 cells highly expressing GFP-vinexin , we sometimes observed vinculin-free dot-like GFP fluorescence, which is apparently aggregation of overexpressed GFP-vinexin fusion protein (Fig. 9, A and B). FLAG-tagged vinexin and vinexin β also localized to focal adhesions, and nontagged vinexin (expressed using clone p3A9) was also detected at focal adhesions by indirect immunostaining with antivinexin polyclonal antibody (data not shown). Thus, vinexin is a novel focal adhesion protein, and it colocalizes with vinculin. Interestingly, increased vinculin staining in focal adhesions was observed in the cells expressing vinexin (Fig. 9, A and B). This finding may indicate the ability of vinexin to recruit vinculin from the diffuse pool to focal adhesions, or to stabilize vinculin in focal adhesions.
|
|
and β were detected at cell–cell adhesions. For unknown reasons, the fluorescence levels of diffuse vinexin and β were high, and vinexin was often aggregated in LLC-PK1 cells.
Vinexin –expressing cells also showed unusually strong rhodamine-phalloidin staining at focal adhesions, so that the actin stress fibers had swollen ends in these cells. This effect was particularly clearly observed by confocal microscopy, as shown in Fig. 10. The actin stress fibers in vinexin –expressing cells were often stained strongly with rhodamine-phalloidin, though it was difficult to quantitate. In vinexin β–expressing cells, modest increases in size of focal adhesions were also observed (Fig. 10, G–I). Similar results were obtained with FLAG-tagged vinexin and β (data not shown). In cells that expressed vinexin at high levels, aggregations of GFP fluorescence or FLAG indirect immunostaining were sometimes observed that lacked colocalized actin (Fig. 10, D and F).
|
(pGFPVxH) was also localized in focal adhesions in NIH 3T3 cells (Fig. 11), indicating the existence of focal adhesion–binding activity in this domain. In contrast to vinexin , expression of the amino-terminal half of vinexin did not change actin cytoskeletal organization (data not shown).
|
–expressing C2C12 cells, or vinexin – and β–expressing NIH 3T3 cells.
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
and β and the vinculin-binding region were expressed in NIH 3T3 cells: all resulted in localizations at focal adhesions. They also localized to cell–cell adhesions in epithelial LLC-PK1 cells. Expression of vinexin also promoted an increase in vinculin staining at focal adhesions. These results were consistent with the notion that vinexin binds to vinculin in vivo. Thus, we propose that vinexin is a novel vinculin-binding protein and also a novel component in focal adhesion and cell–cell adhesion. We identified a novel binding sequence in the primary structure of vinculin. This vinexin-binding sequence was mapped within residues 849–893 of chicken vinculin. It is now well established that SH3 domains bind to proline-rich sequences of which the core sequence is "PXXP," where "P" is a proline residue and "X" for any amino acid other than cysteine (Cohen et al., 1995). As shown in Fig. 7 A, it is possible to assign a pair of putative PXXP motifs in the vinexin-binding region. Exact mapping of the vinexin-binding site remains to be determined. It is also noteworthy that a high level of sequence conservation throughout evolution of the vinexin-binding site of vinculin implies the importance of the interaction between vinculin and vinexin.
The specificity of interaction between single SH3 domain and the proline-rich motif has been studied extensively. To our knowledge, this is the first demonstration that a pair of SH3 domains is required for the specific interaction of two proteins, although a similar multivalency-dependent specificity has been proposed for the interaction between Sos and Grb2 (Lim, 1996). In the case of the SH2 domain, multivalency is known to raise the specificity of SH2 domain interactions of ZAP-70 (Hatada et al., 1995) and SH-PTP2 (Eck et al., 1996). This vinexin–vinculin interaction may provide a valuable insight into the specificity of molecular recognition of multiple binding modules.
The proline-rich region of vinculin has been examined by several studies, and generally considered to be a hinge between the head and tail domains (Jockusch et al., 1995). There are two sites near the vinexin-binding region where V8 protease readily cleaves vinculin (Price et al., 1989). Thus, this region of vinculin is likely to be exposed on the surface of the molecule. It has been shown that the cytoskeletal protein vasodilator-stimulated phosphoprotein (VASP) binds to the adjacent proline-rich stretch (residues 842–846) of vinculin in vitro (Brindle et al., 1996; Reinhard et al., 1996). The binding site of VASP is therefore very close to, but not overlapping with, the vinexin binding sequence (Fig. 7 A). It will be interesting to determine whether VASP and vinexin can access the proline-rich region of vinculin concurrently or exclusively of each other.
Expression of vinexin resulted in a significant increase in the size of focal adhesions and also an increase in actin stress fiber formation. Since the effects of vinexin β expression on actin cytoskeleton was not as conspicuous as vinexin , the amino-terminal half of vinexin (referred to hereafter as VxH domain) was suggeted to play roles in the upregulation of actin cytoskeletal organization. Our results also indicated that the VxH domain can bind to focal adhesions, since it became localized to cell adhesions when the domain alone was expressed in NIH 3T3 cells. Therefore, vinexin contains multiple interaction sites to focal adhesion components, as summarized in Fig. 13. The ligand(s) of the third SH3 domain is unknown at present. In contrast to the conspicuous effects on focal adhesions and stress fibers of vinexin , expression of the VxH domain alone resulted in no apparent effect on focal adhesions and stress fibers. Thus, the VxH and the vinculin-binding domains may act cooperatively to upregulate actin cytoskeletal organization, although the exact molecular mechanism remains to be examined.
|
-actinin, paxillin, and actin. The interaction and assembly of the focal adhesion molecules are complex and highly cooperative processes in which they are efficiently recruited from diffusible pools within the cell and bound to each other to form multimolecular complexes linked to the actin cytoskeleton (Geiger et al., 1992; Jockusch et al., 1995; Yamada and Geiger, 1997; Burridge et al., 1997). At present, it is difficult to determine how vinexin enhances these processes. It is, however, noteworthy that the effect of vinculin overexpression (Geiger et al., 1992) is similar to that of vinexin ; i.e., a significant increase in the size of focal adhesions and stress fibers. A possible cooperative recruitment of vinculin and vinexin to focal adhesions, or stabilization of vinculin, may play an important role, since our results showed that vinculin staining at focal adhesions was markedly enhanced in vinexin –expressing cells.
We found that the effect of vinexin β expression on actin cytoskeletal organization was less than that of vinexin . Nevertheless, when stably transfected cells were assayed for cell-spreading activities on fibronectin, vinexin β–expressing clones showed significantly higher cell-spreading activities than did mock-transfected cell lines. Since conformational alteration of vinculin has been suggested as a mechanism for the modulation of vinculin function (Johnson and Craig, 1994, 1995; Kroemker et al., 1994; Schwienbacher et al., 1996), there is a possibility that vinexin β may enhance cell spreading by modulating vinculin conformation.
Homology searches of DNA and protein databases revealed two other structurally related proteins, CAP and ArgBP2. CAP, also known as SH3P12, was originally isolated as a binding protein to proline-rich sequences in a systematic screening experiment for SH3 domains (Sparks et al., 1996), and later as a binding protein to c-Cbl (Ribon et al., 1998b). ArgBP2 was isolated by a two-hybrid screening for Arg- and Abl-binding proteins (Wang et al., 1997). These two molecules and vinexin each contain three SH3 domains, and CAP and ArgBP2 are most related to each other at the sequence level. There are sequence homologies found in ArgBP2 and CAP with some stretches of amino acid sequence within the vinexin VxH domain. In contrast to vinexin, both CAP and ArgBP2 have been reported to localize with actin stress fibers. Recently, expression of CAP was reported to enhance actin stress fiber formation and focal adhesions, and association of CAP with cytoskeletal signaling molecules such as p125 FAK was suggested (Ribon et al., 1998a). These differences between the two molecules and vinexin in subcellular localization and association partners may indicate related but diverse roles of these molecules.
|
Acknowledgments |
|---|
Submitted: 26 May 1998
Revised: 16 November 1998
Address correspondence to Shin-ichi Aota, Biomolecular Engineering Research Institute, Suita, 6-2-3 Furuedai, Osaka 565-0874, Japan. Tel.: 81-6-872-8208. Fax: 81-6-872-8219. E-mail: aota{at}beri.co.jp
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Aota S, Nomizu M & Yamada KM. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function, J Biol Chem, 1994, 269, 24756–24761.
Brindle NP, Holt MR, Davies JE, Price CJ & Critchley DR. The focal-adhesion vasodilator-stimulated phosphoprotein (VASP) binds to the proline-rich domain in vinculin, Biochem J, 1996, 318, 753–757.[Medline]
Burridge K, Chrzanowska-Wodnicka M & Zhong C. Focal adhesion assembly, Trends Cell Biol, 1997, 7, 342–347.[Medline]
Chien CT, Bartel PL, Sternglanz R & Fields S. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest, Proc Natl Acad Sci USA, 1991, 88, 9578–9582.
Cohen GB, Ren R & Baltimore D. Modular binding domains in signal transduction proteins, Cell, 1995, 80, 237–248.[Medline]
Coll JL, Ben-Ze'ev A, Ezzell RM, Rodríguez JL, Fernández, Baribault H, Oshima RG & Adamson ED. Targeted disruption of vinculin genes in F9 and embryonic stem cells changes cell morphology, adhesion, and locomotion, Proc Natl Acad Sci USA, 1995, 92, 9161–9165.
Cormack BP, Valdivia RH & Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP), Gene, 1996, 173, 33–38.[Medline]
Eck MJ, Pluskey S, Trub T, Harrison SC & Shoelson SE. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2, Nature, 1996, 379, 277–280.[Medline]
Fields S & Song O. A novel genetic system to detect protein–protein interactions, Nature, 1989, 340, 245–246.[Medline]
Geiger B, Ayalon O, Ginsberg D, Volberg T, Rodríguez JL, Fernández, Yarden Y & Ben-Ze'ev A. Cytoplasmic control of cell adhesion, Cold Spring Harbor Symp Quant Biol, 1992, 57, 631–642.
Gilmore AP & Burridge K. Regulation of vinculin binding to talin and actin by phosphatidyl-inositol-4-5-bisphosphate, Nature, 1996, 381, 531–535.[Medline]
Goldmann WH, Schindl M, Cardozo TJ & Ezzell RM. Motility of vinculin-deficient F9 embryonic carcinoma cells analyzed by video, laser confocal, and reflection interference contrast microscopy, Exp Cell Res, 1995, 221, 311–319.[Medline]
Hatada MH, Lu X, Laird ER, Green J, Morgenstern JP, Lou M, Marr CS, Phillips TB, Ram MK, Theriault K, Zoller MJ & Karas JL. Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor, Nature, 1995, 377, 32–38.[Medline]
Jockusch BM, Bubeck P, Giehl K, Kroemker M, Moschner J, Rothkegel M, Rudiger M, Schluter K, Stanke G & Winkler J. The molecular architecture of focal adhesions, Annu Rev Cell Dev Biol, 1995, 11, 379–416.[Medline]
Johnson RP & Craig SW. An intramolecular association between the head and tail domains of vinculin modulates talin binding, J Biol Chem, 1994, 269, 12611–12619.
Johnson RP & Craig SW. F-actin binding site masked by the intramolecular association of vinculin head and tail domains, Nature, 1995, 373, 261–264.[Medline]
Kroemker M, Rudiger AH, Jockusch BM & Rudiger M. Intramolecular interactions in vinculin control alpha-actinin binding to the vinculin head, FEBS Lett, 1994, 355, 259–262.[Medline]
Lim WA. Reading between the lines: SH3 recognition of an intact protein, Structure, 1996, 4, 657–659.[Medline]
Milam LM. Electron microscopy of rotary shadowed vinculin and vinculin complexes, J Mol Biol, 1985, 184, 543–545.[Medline]
Molony L & Burridge K. Molecular shape and self-association of vinculin and metavinculin, J Cell Biochem, 1985, 29, 31–36.[Medline]
Price GJ, Jones P, Davison MD, Patel B, Bendori R, Geiger B & Critchley DR. Primary sequence and domain structure of chicken vinculin, Biochem J, 1989, 259, 453–461.[Medline]
Reinhard M, Rudiger M, Jockusch BM & Walter U. VASP interaction with vinculin: a recurring theme of interactions with proline-rich motifs, FEBS Lett, 1996, 399, 103–107.[Medline]
Ribon V, Herrera R, Kay BK & Saltiel AR. A role for CAP, a novel, multifunctional Src Homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions, J Biol Chem, 1998a, 273, 4073–4080.
Ribon V, Printen JA, Hoffman NG, Kay BK & Saltiel AR. A novel, multifunctional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes, Mol Cell Biol, 1998b, 18, 872–879.
Rodríguez Fernández, J.L., B. Geiger, D. Salomon, and A. Ben-Ze'ev. Suppression of vinculin expression by antisense transfection confers changes in cell morphology, motility, and anchorage-dependent growth of 3T3 cells, J Cell Biol, 1993, 122, 1285–1294.
Schwienbacher C, Jockusch BM & Rudiger M. Intramolecular interactions regulate serine/threonine phosphorylation of vinculin, FEBS Lett, 1996, 384, 71–74.[Medline]
Sparks AB, Hoffman NG, McConnell SJ, Fowlkes DM & Kay BK. Cloning of ligand targets: systematic cloning of functional SH3 domains, Nat Biotechnol, 1996, 14, 741–744.[Medline]
Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T & Hori R. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1), J Pharmacol Exp Ther, 1992, 263, 840–845.
Varnum-Finney B & Reichardt LF. Vinculin-deficient PC12 cell lines extend unstable lamellipodia and filopodia and have a reduced rate of neurite outgrowth, J Cell Biol, 1994, 127, 1071–1084.
Volberg T, Geiger B, Kam Z, Pankov R, Simcha I, Sabanay H, Coll JL, Adamson E & Ben-Ze'ev A. Focal adhesion formation by F9 embryonal carcinoma cells after vinculin gene disruption, J Cell Sci, 1995, 108, 2253–2260.[Abstract]
Wang B, Golemis EA & Kruh GD. ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks, J Biol Chem, 1997, 272, 17542–17550.
Weekes J, Barry ST & Critchley DR. Acidic phospholipids inhibit the intramolecular association between the N- and C-terminal regions of vinculin, exposing actin-binding and protein kinase C phosphorylation sites, Biochem J, 1996, 314, 827–832.[Medline]
Yaffe D & Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle, Nature, 1977, 270, 725–727.[Medline]
Yamada KM & Geiger B. Molecular interactions in cell adhesion complexes, Curr Opin Cell Biol, 1997, 9, 76–85.[Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
